Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...

Dividend-screened portfolios of various kinds have failed to keep up with the broad US stock market over the past 10 years, ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

The Senate confirms Lee Zeldin to lead the E.P.A. The Justice Dept. seeks to have criminal charges dismissed against a former Republican representative. Trump signs Laken Riley Act, a law to make ...

An accounting provided by Hamas over the weekend confirmed intelligence assessments, Israeli officials said. By Isabel Kershner People were trampled as pilgrims at the Maha Kumbh Mela, one of ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

Shares closed down in their first day of trading. CEO Shane Smith said the company is at its peak despite threats of tariffs and concerns over its Chinese ownership. Gunjan Kedia is set to take th ...